These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 35442721)
21. Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility. Johnson N; Fletcher O; Palles C; Rudd M; Webb E; Sellick G; dos Santos Silva I; McCormack V; Gibson L; Fraser A; Leonard A; Gilham C; Tavtigian SV; Ashworth A; Houlston R; Peto J Hum Mol Genet; 2007 May; 16(9):1051-7. PubMed ID: 17341484 [TBL] [Abstract][Full Text] [Related]
22. Environmental Aldehyde Sources and the Health Implications of Exposure. Sinharoy P; McAllister SL; Vasu M; Gross ER Adv Exp Med Biol; 2019; 1193():35-52. PubMed ID: 31368096 [TBL] [Abstract][Full Text] [Related]
23. Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Spurdle AB; Marquart L; McGuffog L; Healey S; Sinilnikova O; Wan F; Chen X; Beesley J; Singer CF; Dressler AC; Gschwantler-Kaulich D; Blum JL; Tung N; Weitzel J; Lynch H; Garber J; Easton DF; Peock S; Cook M; Oliver CT; Frost D; Conroy D; Evans DG; Lalloo F; Eeles R; Izatt L; Davidson R; Chu C; Eccles D; Selkirk CG; Daly M; Isaacs C; Stoppa-Lyonnet D; Sinilnikova OM; Buecher B; Belotti M; Mazoyer S; Barjhoux L; Verny-Pierre C; Lasset C; Dreyfus H; Pujol P; Collonge-Rame MA; ; Rookus MA; Verhoef S; Kriege M; Hoogerbrugge N; Ausems MG; van Os TA; Wijnen J; Devilee P; Meijers-Heijboer HE; Blok MJ; Heikkinen T; Nevanlinna H; Jakubowska A; Lubinski J; Huzarski T; Byrski T; Durocher F; Couch FJ; Lindor NM; Wang X; Thomassen M; Domchek S; Nathanson K; Caligo M; Jernström H; Liljegren A; Ehrencrona H; Karlsson P; ; Ganz PA; Olopade OI; Tomlinson G; Neuhausen S; Antoniou AC; Chenevix-Trench G; Rebbeck TR Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):1032-8. PubMed ID: 21393566 [TBL] [Abstract][Full Text] [Related]
24. Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Hashibe M; Boffetta P; Zaridze D; Shangina O; Szeszenia-Dabrowska N; Mates D; Janout V; Fabiánová E; Bencko V; Moullan N; Chabrier A; Hung R; Hall J; Canzian F; Brennan P Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):696-703. PubMed ID: 16614111 [TBL] [Abstract][Full Text] [Related]
25. Genetic testing in Poland and Ukraine: should comprehensive germline testing of Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980 [TBL] [Abstract][Full Text] [Related]
26. Comparing the frequency of common genetic variants and haplotypes between carriers and non-carriers of BRCA1 and BRCA2 deleterious mutations in Australian women diagnosed with breast cancer before 40 years of age. Turkovic L; Gurrin LC; Bahlo M; Dite GS; Southey MC; Hopper JL BMC Cancer; 2010 Sep; 10():466. PubMed ID: 20807450 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Stevens KN; Wang X; Fredericksen Z; Pankratz VS; Greene MH; Andrulis IL; Thomassen M; Caligo M; ; Nathanson KL; Jakubowska A; Osorio A; Hamann U; Godwin AK; Stoppa-Lyonnet D; Southey M; Buys SS; Singer CF; Hansen TV; Arason A; Offit K; Piedmonte M; Montagna M; Imyanitov E; Tihomirova L; Sucheston L; Beattie M; ; ; Neuhausen SL; ; Szabo CI; ; Simard J; Spurdle AB; Healey S; Chen X; Rebbeck TR; Easton DF; Chenevix-Trench G; Antoniou AC; Couch FJ Breast Cancer Res Treat; 2012 Nov; 136(1):295-302. PubMed ID: 23011509 [TBL] [Abstract][Full Text] [Related]
28. Homozygous ALDH2*2 Is an Independent Risk Factor for Ischemic Stroke in Taiwanese Men. Sung YF; Lu CC; Lee JT; Hung YJ; Hu CJ; Jeng JS; Chiou HY; Peng GS Stroke; 2016 Sep; 47(9):2174-9. PubMed ID: 27486170 [TBL] [Abstract][Full Text] [Related]
29. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou AC; Beesley J; McGuffog L; Sinilnikova OM; Healey S; Neuhausen SL; Ding YC; Rebbeck TR; Weitzel JN; Lynch HT; Isaacs C; Ganz PA; Tomlinson G; Olopade OI; Couch FJ; Wang X; Lindor NM; Pankratz VS; Radice P; Manoukian S; Peissel B; Zaffaroni D; Barile M; Viel A; Allavena A; Dall'Olio V; Peterlongo P; Szabo CI; Zikan M; Claes K; Poppe B; Foretova L; Mai PL; Greene MH; Rennert G; Lejbkowicz F; Glendon G; Ozcelik H; Andrulis IL; ; Thomassen M; Gerdes AM; Sunde L; Cruger D; Birk Jensen U; Caligo M; Friedman E; Kaufman B; Laitman Y; Milgrom R; Dubrovsky M; Cohen S; Borg A; Jernström H; Lindblom A; Rantala J; Stenmark-Askmalm M; Melin B; ; Nathanson K; Domchek S; Jakubowska A; Lubinski J; Huzarski T; Osorio A; Lasa A; Durán M; Tejada MI; Godino J; Benitez J; Hamann U; Kriege M; Hoogerbrugge N; van der Luijt RB; van Asperen CJ; Devilee P; Meijers-Heijboer EJ; Blok MJ; Aalfs CM; Hogervorst F; Rookus M; ; Cook M; Oliver C; Frost D; Conroy D; Evans DG; Lalloo F; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Hodgson S; Morrison PJ; Porteous ME; Walker L; Kennedy MJ; Dorkins H; Peock S; ; Godwin AK; Stoppa-Lyonnet D; de Pauw A; Mazoyer S; Bonadona V; Lasset C; Dreyfus H; Leroux D; Hardouin A; Berthet P; Faivre L; ; Loustalot C; Noguchi T; Sobol H; Rouleau E; Nogues C; Frénay M; Vénat-Bouvet L; ; Hopper JL; Daly MB; Terry MB; John EM; Buys SS; Yassin Y; Miron A; Goldgar D; ; Singer CF; Dressler AC; Gschwantler-Kaulich D; Pfeiler G; Hansen TV; Jønson L; Agnarsson BA; Kirchhoff T; Offit K; Devlin V; Dutra-Clarke A; Piedmonte M; Rodriguez GC; Wakeley K; Boggess JF; Basil J; Schwartz PE; Blank SV; Toland AE; Montagna M; Casella C; Imyanitov E; Tihomirova L; Blanco I; Lazaro C; Ramus SJ; Sucheston L; Karlan BY; Gross J; Schmutzler R; Wappenschmidt B; Engel C; Meindl A; Lochmann M; Arnold N; Heidemann S; Varon-Mateeva R; Niederacher D; Sutter C; Deissler H; Gadzicki D; Preisler-Adams S; Kast K; Schönbuchner I; Caldes T; de la Hoya M; Aittomäki K; Nevanlinna H; Simard J; Spurdle AB; Holland H; Chen X; ; Platte R; Chenevix-Trench G; Easton DF; Cancer Res; 2010 Dec; 70(23):9742-54. PubMed ID: 21118973 [TBL] [Abstract][Full Text] [Related]
30. Novel BRCA2 pathogenic genotype and breast cancer phenotype discordance in monozygotic triplets. Duzkale N; Eyerci N; Oksuzoglu B; Teker T; Kandemir O Eur J Med Genet; 2020 Apr; 63(4):103771. PubMed ID: 31563594 [TBL] [Abstract][Full Text] [Related]
31. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Kamino K; Nagasaka K; Imagawa M; Yamamoto H; Yoneda H; Ueki A; Kitamura S; Namekata K; Miki T; Ohta S Biochem Biophys Res Commun; 2000 Jun; 273(1):192-6. PubMed ID: 10873585 [TBL] [Abstract][Full Text] [Related]
32. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism. Gochhait S; Bukhari SI; Bairwa N; Vadhera S; Darvishi K; Raish M; Gupta P; Husain SA; Bamezai RN Breast Cancer Res; 2007; 9(5):R71. PubMed ID: 17945002 [TBL] [Abstract][Full Text] [Related]
33. Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs. Li N; Rowley SM; Thompson ER; McInerny S; Devereux L; Amarasinghe KC; Zethoven M; Lupat R; Goode D; Li J; Trainer AH; Gorringe KL; James PA; Campbell IG Breast Cancer Res; 2018 Jan; 20(1):3. PubMed ID: 29316957 [TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males. Ding JH; Li SP; Cao HX; Wu JZ; Gao CM; Su P; Liu YT; Zhou JN; Chang J; Yao GH World J Gastroenterol; 2009 May; 15(19):2395-400. PubMed ID: 19452585 [TBL] [Abstract][Full Text] [Related]
36. East asian variant of aldehyde dehydrogenase 2 is associated with coronary spastic angina: possible roles of reactive aldehydes and implications of alcohol flushing syndrome. Mizuno Y; Harada E; Morita S; Kinoshita K; Hayashida M; Shono M; Morikawa Y; Murohara T; Nakayama M; Yoshimura M; Yasue H Circulation; 2015 May; 131(19):1665-73. PubMed ID: 25759460 [TBL] [Abstract][Full Text] [Related]
37. [Importance of an Aldehyde Dehydrogenase 2 Polymorphism in Preventive Medicine]. Matsumoto A Nihon Eiseigaku Zasshi; 2018; 73(1):9-20. PubMed ID: 29386454 [TBL] [Abstract][Full Text] [Related]
38. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families. Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231 [TBL] [Abstract][Full Text] [Related]
39. Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk. Strojnik K; Krajc M; Dragos VS; Stegel V; Novakovic S; Blatnik A Breast Cancer Res Treat; 2021 Aug; 188(3):811-820. PubMed ID: 33891299 [TBL] [Abstract][Full Text] [Related]
40. The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Kaufman B; Laitman Y; Ziv E; Hamann U; Torres D; Lahad EL; Beeri R; Renbaum P; Jakubowska A; Lubinski J; Huzarski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Sprudle AB; Chenevix-Trench G; Simard J; Easton DF; Antonis A; Szabo C; Friedman E Breast Cancer Res Treat; 2011 Apr; 126(2):521-7. PubMed ID: 20798986 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]